NASDAQ:CHTP - Chelsea Therapeutics International Stock Price, Price Target & More

Previous CloseN/A
Today's RangeN/A
52-Week RangeN/A
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A

About Chelsea Therapeutics International (NASDAQ:CHTP)

Chelsea Therapeutics International logoChelsea Therapeutics International, Ltd. is a development stage pharmaceutical company that focuses on acquiring, developing and commercializing products for the treatment of a variety of human diseases. The Company is developing a therapeutic agent for the treatment of symptomatic neurogenic orthostatic hypotension (NOH), associated with primary autonomic failure and falls related to NOH in Parkinson's Disease (PD), as well as other norepinephrine-related conditions and diseases, including intradialytic hypotension (IDH), fibromyalgia, adult attention deficit hyperactivity disorder (ADHD), chronic fatigue syndrome (CFS), freezing of gait in PD and Down syndrome. In addition, the Company is developing a portfolio of metabolically inert antifolates for the treatment of rheumatoid arthritis and is exploring potential applications in multiple other autoimmune disorders.

Receive CHTP News and Ratings via Email

Sign-up to receive the latest news and ratings for CHTP and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry N/A


Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A


Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A


EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A


Outstanding SharesN/A

How to Become a New Pot Stock Millionaire

Chelsea Therapeutics International (NASDAQ:CHTP) Frequently Asked Questions

What is Chelsea Therapeutics International's stock symbol?

Chelsea Therapeutics International trades on the NASDAQ under the ticker symbol "CHTP."

Who are some of Chelsea Therapeutics International's key competitors?

Has Chelsea Therapeutics International been receiving favorable news coverage?

Media coverage about CHTP stock has trended somewhat positive this week, Accern reports. Accern rates the sentiment of media coverage by reviewing more than 20 million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Chelsea Therapeutics International earned a media sentiment score of 0.16 on Accern's scale. They also assigned press coverage about the healthcare company an impact score of 44.54 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the company's share price in the immediate future.

How do I buy shares of Chelsea Therapeutics International?

Shares of CHTP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How can I contact Chelsea Therapeutics International?

Chelsea Therapeutics International's mailing address is 3530 Toringdon Way Ste 200, CHARLOTTE, NC 28277-3436, United States. The healthcare company can be reached via phone at +1-704-3411516.

MarketBeat Community Rating for Chelsea Therapeutics International (CHTP)

Community Ranking:  2.9 out of 5 (star star)
Outperform Votes:  99 (Vote Outperform)
Underperform Votes:  72 (Vote Underperform)
Total Votes:  171
MarketBeat's community ratings are surveys of what our community members think about Chelsea Therapeutics International and other stocks. Vote "Outperform" if you believe CHTP will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CHTP will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Chelsea Therapeutics International (NASDAQ:CHTP) Analyst Ratings History

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
(Data available from 4/23/2016 forward)


Chelsea Therapeutics International (NASDAQ:CHTP) Earnings History and Estimates Chart

Earnings by Quarter for Chelsea Therapeutics International (NASDAQ:CHTP)

Chelsea Therapeutics International (NASDAQ CHTP) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
3/11/2014Q413($0.07)($0.07)ViewN/AView Earnings Details
11/5/2013Q3 2013($0.06)($0.06)ViewN/AView Earnings Details
8/6/2013Q2 2013($0.06)($0.05)ViewN/AView Earnings Details
5/1/2013Q1 2013($0.05)($0.06)ViewN/AView Earnings Details
3/7/2013Q4 2012($0.08)($0.03)ViewN/AView Earnings Details
11/7/2012Q3 2012($0.11)($0.06)ViewN/AView Earnings Details
8/7/2012Q2 2012($0.19)($0.12)ViewN/AView Earnings Details
5/1/2012Q1 2012($0.23)($0.23)ViewN/AView Earnings Details
3/6/2012Q4 2011($0.33)($0.20)ViewN/AView Earnings Details
11/2/2011Q3 2011($0.27)($0.18)ViewN/AView Earnings Details
7/26/2011Q2 2011($0.25)($0.22)ViewN/AView Earnings Details
5/9/2011Q1 2011($0.23)($0.25)ViewN/AView Earnings Details
3/2/2011Q4 2010($0.23)($0.25)ViewN/AView Earnings Details
11/1/2010Q3 2010($0.28)($0.22)ViewN/AView Earnings Details
7/27/2010Q2 2010($0.21)($0.25)ViewN/AView Earnings Details
4/29/2010Q1 2010($0.19)($0.18)ViewN/AView Earnings Details
3/10/2010Q4 2009($0.23)($0.18)ViewN/AView Earnings Details
11/2/2009Q3 2009($0.28)($0.22)ViewN/AView Earnings Details
8/5/2009Q2 2009($0.27)($0.31)ViewN/AView Earnings Details
5/6/2009Q1 2009($0.31)($0.24)ViewN/AView Earnings Details
3/4/2009Q4 2008($0.29)($0.28)ViewN/AView Earnings Details
11/5/2008Q3 2008($0.27)($0.27)ViewN/AView Earnings Details
8/6/2008Q2 2008($0.26)($0.24)ViewN/AView Earnings Details
5/12/2008Q1 2008($0.23)($0.29)ViewN/AView Earnings Details
3/11/2008Q4 2007($0.24)($0.18)ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)


Chelsea Therapeutics International (NASDAQ:CHTP) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Chelsea Therapeutics International (NASDAQ CHTP) Insider Trading and Institutional Ownership History

Insider Trading History for Chelsea Therapeutics International (NASDAQ:CHTP)

Chelsea Therapeutics International (NASDAQ CHTP) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
(Data available from 1/1/2013 forward)


Chelsea Therapeutics International (NASDAQ CHTP) News Headlines

No headlines for this company have been tracked by

SEC Filings

Chelsea Therapeutics International (NASDAQ:CHTP) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media


Chelsea Therapeutics International (NASDAQ:CHTP) Income Statement, Balance Sheet and Cash Flow Statement


Chelsea Therapeutics International (NASDAQ CHTP) Stock Chart for Monday, April, 23, 2018

Loading chart…

This page was last updated on 4/23/2018 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.